Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
[Advanced]

The most recent version of this article was published on 1 February 2006

Gut. Published Online First: 15 November 2005. doi:10.1136/gut.2005.064980
Copyright © 2005 BMJ Publishing Group Ltd & British Society of Gastroenterology

This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
gut.2005.064980v1
55/2/259    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, L.
Right arrow Articles by Qiao, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, L.
Right arrow Articles by Qiao, M.
Topic Collections
Right arrowRelevant Article

Paper

Treatment of pancreatic carcinoma by adenoviral mediated gene transfer of vasostatin in mice

Lei Li 1, Yaozong Yuan 1*, Jian Lu 2, Lu Xia 1, Ying Zhu 1, Yongping Zhang 1 and Minmin Qiao 1

1 Department of Gastroenterology, Ruijin Hospital, Shanghai Second Medical University, China
2 Department of Biochemistry and Center of Human Gene Therapy, Shanghai Second Medical University, China

* To whom correspondence should be addressed. E-mail: yyz28{at}medmail.com.cn.

Accepted 28 September 2005


*  Abstract

Background: Tumor growth is angiogenesis- dependent and antiangiogenesis therapy may represent a promising therapeutic option.

Aims: To evaluate the inhibitory effect of vasostatin gene mediated by a replication-deficient recombinant adenovirus on human pancreatic cancer in vivo and to investigate the mechanism of vasostatin.

Methods: Human umbilical vein endothelium derived ECV304 cells were infected with Ad-vasostatin and Ad- lacZ, compared with PBS. MTT assay was used to estimate the proliferation of ECV304 cells; tube formation assay and choriallantoic membrance assay were used to evaluate angiogenesis in vitro and in vitro. The xenografted nude mice with pancreatic cancer were established to observe the in vivo tumor growth suppression. The microvessel density revealed by CD31 immunohistochemical staining was measured.

Results: The growth and tube formation of ECV304 cells infected with Ad-vasostatin was suppressed significantly compared with that of cells infected with Ad-lacZ or cells treated with PBS. The neovascularization in Ad-vasostatin group was less than these in PBS group and in Ad-lacZ group according to the CAM results. The volumes of pancreastic tumors in Ad- vasostatin group were smaller significantly than these in PBS group and in Ad-lacZ group at the end of the treatment period. The microvessel density of the Ad- vasostatin group was significantly lower than that of the Ad-lacZ group and the PBS group.

Conclusion: The vasostatin gene mediated by adenovirus is efficient for gene therapy for pancreatic carcinoma. The suppression of vasostatin on the proliferation of vasocular endothelium cells and angiogenesis may account for its effect.


Keywords: adenoviral vectors, antiangiogenesis, gene therapy, pancreatic neoplasms, vasostatin


Relevant Article

Digest
Robin Spiller and Alistair Watson
Gut 2006 55: 141. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
K. X. Cai, L. Y. Tse, C. Leung, P. K.H. Tam, R. Xu, and M. H. Sham
Suppression of Lung Tumor Growth and Metastasis in Mice by Adeno-Associated Virus-Mediated Expression of Vasostatin
Clin. Cancer Res., February 1, 2008; 14(3): 939 - 949.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 BMJ Publishing Group Ltd & British Society of Gastroenterology